Valuation: Healius Limited

Market Cap 392M 267M 241M 223M 202M 381M 25.1B 2.68B 1.06B 13.42B 1B 981M 42.72B P/E 2027 *
100x
P/E 2028 * -114x
Enterprise Value 1.17B 796M 720M 664M 601M 1.13B 74.83B 7.98B 3.17B 40B 2.99B 2.92B 127B EV / Sales 2027 *
0.84x
EV / Sales 2028 * 0.83x
Free-Float
77.69%
Yield 2027 *
-
Yield 2028 * 1.45%
1 day+2.86%
1 week+10.20%
Current month+9.09%
1 month+38.46%
3 months+25.58%
6 months+6.93%
Current year-40.33%
1 week 0.48
Extreme 0.482
0.55
1 month 0.36
Extreme 0.365
0.55
Current year 0.3
Extreme 0.3
1.05
1 year 0.3
Extreme 0.3
1.07
3 years 0.3
Extreme 0.3
1.95
5 years 0.3
Extreme 0.3
5.54
10 years 0.3
Extreme 0.3
5.54
Manager TitleAgeSince
Chief Executive Officer - 05/03/2024
Director of Finance/CFO - 13/10/2025
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member - 21/08/2018
Chairman 65 28/11/2023
Director/Board Member - -
Date Insider Type Main position Quantity % Market Cap. Importance
27/10/26 Buy

Chief Executive Officer

117,433 0.0162%
26/10/26 Buy

Director

35,000 0.0048%
23/10/26 Buy

Chief Executive Officer

232,941 0.0321%
Change 5-day change 1-year change 3-year change Capi.($)
+2.86%+10.20%-38.29%-69.49% 261M
+0.35%+10.38%+11.85%+32.40% 115B
-1.09%-1.34%+5.71%+117.69% 106B
+0.95%-11.17%+54.24%+565.72% 46.38B
+0.64%+2.80%+8.04%+110.94% 33.01B
-0.02%+2.44%+39.91%+82.07% 30.23B
+0.37%+1.84%+38.84%+96.01% 28.46B
-2.07%+0.12%+43.41%+422.70% 23.32B
+0.33%+0.09%-18.10%-16.30% 19.85B
+1.42%+0.77%-5.54%+33.11% 16.77B
Average +0.37%+0.36%+14.01%+137.48% 42B
Weighted average by Cap. -0.05%+1.32%+18.17%+146.55%

Financials

2027 *2028 *
Net sales 1.39B 944M 854M 788M 714M 1.35B 88.79B 9.46B 3.76B 47.47B 3.54B 3.47B 151B 1.41B 963M 871M 804M 728M 1.37B 90.56B 9.65B 3.84B 48.42B 3.62B 3.54B 154B
Net income -2.77M -1.88M -1.7M -1.57M -1.42M -2.69M -177M -18.87M -7.5M -94.65M -7.07M -6.92M -301M -4.35M -2.96M -2.68M -2.47M -2.24M -4.22M -278M -29.65M -11.78M -149M -11.11M -10.87M -473M
Net Debt 777M 529M 478M 442M 400M 754M 49.73B 5.3B 2.11B 26.58B 1.99B 1.94B 84.62B 776M 529M 478M 441M 399M 754M 49.7B 5.3B 2.11B 26.57B 1.98B 1.94B 84.58B
Projected Income Statement - Annual - Healius Limited
Logo Healius Limited
Healius Limited is a healthcare company. The Company's specialized pathology businesses deliver healthcare services across Australia. It provides pathology services, including specialty pathology and clinical trials. It offers medical laboratory and pathology services through a variety of specialty brands. It provides medical laboratory and pathology services across key diagnostic activities. These include anatomical pathology (histopathology and cytology), clinical pathology (biochemistry, hematology, immunology and microbiology), genomic diagnostics and veterinary pathology. Its brands include Abbot, Agilex Biolabs, Dorevitch, Gastrolab, Genomic Diagnostics, IQ Pathology, Kossard Dermatopathology, Laverty Pathology, QML Pathology, TML Pathology, Vetnostics Pathology and Western Diagnostic Pathology (WDP). These brands operate in Queensland, New South Wales (including the Australian Capital Territory), Victoria, Western Australia and Northern Territory, Tasmania, and South Australia.
Employees
5,419
Date Price Change Volume
12/11/26 A$0.5400 +2.86% 4,267,242
11/11/26 A$0.5250 -0.94% 908,250
10/11/26 A$0.5300 +1.92% 4,118,455
09/11/26 A$0.5200 +4.00% 6,285,612
06/11/26 A$0.5000 +1.01% 1,024,031
Trader
Investor
Global
Quality
ESG MSCI
AA
MarketScreener Ratings - Healius Limited
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
10
Last Close Price
0.5400AUD
Average target price
0.5498AUD
Spread / Average Target
+1.82%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Healius Limited